Preventing Depression Recurrence in Diabetes
To study the effectiveness of sertraline (Zoloft) in treating depression in adults with diabetes. The study will also determine whether depressed diabetic patients who have successfully responded to sertraline (Zoloft) are more likely to have depression recur if the sertraline (Zoloft) is discontinued.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Preventing Depression Recurrence in Diabetes|
|Study Start Date:||March 1998|
|Estimated Study Completion Date:||October 2004|
Part A: Prevention of Depression Recurrence in Diabetes
- To determine the efficacy of maintenance antidepressant medication in preventing or delaying recur-rence of major depression in diabetes.
- To determine the relationship of sustained depression remission to social, occupational, and global func-tioning, and to quality of life and compliance with diabetes treatment.
- To determine clinical features predictive of depression recurrence in diabetes.
Part B. Longitudinal Study of the Interrelationship of Glycemic Control and Depression
- To determine the effects of depression remission and recurrence on glycemic control.
- To determine the efficacy of maintenance antidepressant medication in producing sustained benefits in glycemic control.
- To determine the interrelationship of daily mood with blood glucose and the effect of maintenance treatment on this relationship.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00374426
|United States, Missouri|
|Washington University School of Medicine|
|St. Louis, Missouri, United States, 63110|
|Principal Investigator:||Patrick J Lustman, Ph.D.||Washington University School of Medicine|